LB
Lexaria Bioscience Corp
🇺🇸XNAS.LEXXWUnited StatesHealthcare
$0.00USDdown -0.01 (-100%)OpenDelayed6:10 PM
Price$0.00-0.01 (-100%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA52886N1024
- CUSIP
- Not reported
Company
- Employees
- 7
- Headquarters
- Kelowna, United States
- CEO
- Mr. Richard C. Christopher
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$4.74
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $194K-68.5%down year on year
- Net income
- -$7.73M+32.12%up year on year
- Gross margin
- 62.8%-31.37%down year on year
- Free cash flow
- -$7.53M+23.61%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.